5 March 2015 -- Based on promising data from initial clinical trials in late 2014, WHO, with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola. The vaccine was developed by the Public Health Agency of Canada. A second vaccine will be tested in a sequential study, as supply becomes available.
4 March 2015 --- A new WHO guideline recommends adults and children reduce their daily intake of free sugars to less than 10% of their total energy intake. An additional reduction to below 5% of total energy intake or roughly 25 grams (6 teaspoons) per day would provide additional health benefits. Much of the sugars consumed today are “hidden” in processed foods that are not usually seen as sweets.
2 March 2015 -- Every day, every bed in an Ebola treatment unit creates approximately 300 litres of liquid waste. Managing this waste has been a challenge in the Ebola outbreak in Liberia. WHO is working with partners to ensure this waste is effectively decontaminated and no longer poses a threat to health.
27 February 2015 -- Some 1.1 billion teenagers and young adults are at risk of hearing loss due to the unsafe use of personal audio devices, including smartphones, and exposure to damaging levels of sound at noisy entertainment venues such as nightclubs, bars and sporting events, according to WHO. Hearing loss has potentially devastating consequences for physical and mental health, education and employment.